BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24915935)

  • 1. Dose-dependent uptake of 3'-deoxy-3'-[(18) F]fluorothymidine by the bowel after total-body irradiation.
    Hartenbach M; Delker A; Hartenbach S; Schlichtiger J; Niedermoser S; Wängler C; Wängler B; Böning G; Gildehaus FJ; Neumaier K; Lauber K; Kraft K; Belka C; Hacker M; Meineke V; Bartenstein P
    Mol Imaging Biol; 2014 Dec; 16(6):846-53. PubMed ID: 24915935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
    Lin C; Kume K; Mori T; Martinez ME; Okazawa H; Kiyono Y
    J Nucl Med; 2015 Jun; 56(6):945-50. PubMed ID: 25766892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
    Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
    J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ¹⁸F-FDG and ¹⁸F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy.
    Wang H; Liu B; Tian J; Xu B; Zhang J; Qu B; Chen Y
    Eur J Radiol; 2013 Sep; 82(9):e484-91. PubMed ID: 23639776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the early biologic response of esophageal carcinoma after irradiation with 18F-FLT: an in-vitro and in-vivo study.
    Jiang M; Huang Q; Chen P; Ruan X; Luo Z; Zhao L; Fan W; Peng T; Sun L; Wu H
    Nucl Med Commun; 2014 Dec; 35(12):1212-9. PubMed ID: 25192190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
    Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT-PET imaging of radiation responses in murine tumors.
    Pan MH; Huang SC; Liao YP; Schaue D; Wang CC; Stout DB; Barrio JR; McBride WH
    Mol Imaging Biol; 2008; 10(6):325-34. PubMed ID: 18670825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.
    Rendon DA; Kotedia K; Afshar SF; Punia JN; Sabek OM; Shirkey BA; Zawaski JA; Gaber MW
    J Nucl Med; 2016 Feb; 57(2):266-71. PubMed ID: 26315835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
    Apisarnthanarax S; Alauddin MM; Mourtada F; Ariga H; Raju U; Mawlawi O; Han D; Bornmann WG; Ajani JA; Milas L; Gelovani JG; Chao KS
    Clin Cancer Res; 2006 Aug; 12(15):4590-7. PubMed ID: 16899606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse model.
    Meindl M; Bläske A; Steiger K; Lindner S; Lindheimer F; Lauber K; Brix N; von Ungern-Sternberg B; Oos R; Palumbo G; Böning G; Schüle S; Majewski M; Port M; Ziegler S; Bartenstein P
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):395-404. PubMed ID: 37796306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
    Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
    J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
    Bradshaw TJ; Yip S; Jallow N; Forrest LJ; Jeraj R
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):399-405. PubMed ID: 24685446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.
    Yang YJ; Ryu JS; Kim SY; Oh SJ; Im KC; Lee H; Lee SW; Cho KJ; Cheon GJ; Moon DH
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):412-9. PubMed ID: 16404598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
    Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.
    Menda Y; Boles Ponto LL; Dornfeld KJ; Tewson TJ; Watkins GL; Schultz MK; Sunderland JJ; Graham MM; Buatti JM
    J Nucl Med; 2009 Jul; 50(7):1028-35. PubMed ID: 19525472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT.
    Grudzinski JJ; Floberg JM; Mudd SR; Jeffery JJ; Peterson ET; Nomura A; Burnette RR; Tomé WA; Weichert JP; Jeraj R
    Phys Med Biol; 2012 Mar; 57(6):1641-57. PubMed ID: 22398155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of [
    Rapic S; Vangestel C; Verhaeghe J; Thomae D; Pauwels P; Van den Wyngaert T; Staelens S; Stroobants S
    Mol Imaging Biol; 2017 Feb; 19(1):109-119. PubMed ID: 27324368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.